EGFR and non-small cell lung carcinoma: However, when NSCLC cell lines harboring the EGFR T790M mutation were irradiated, the half maximal inhibitory concentration (IC50) of TKI therapy demonstrated a statistically significant decrease compared to the same cell line that did not receive radiation [39].